Key takeaways
- Screening healthy people is different from testing someone with symptoms; it can cause harm through false alarms and over-treatment.
- The UK National Screening Committee advises ministers and the NHS in all four nations on population screening[1]; use its view as a benchmark.
- Consent must cover what a result could lead to, not just what the test is.
- Whoever offers a screen owns the follow-up of every abnormal and incidental finding.
Demand is real, and so are the risks
People are increasingly willing to pay for their health. 71% of UK adults say they would consider private healthcare if they needed treatment[2], and self-pay accounts for 31% of private admissions[3]. Private screening packages, from blood panels to scans, sit at the front of that demand because they promise reassurance without a referral.
- Insured 69%
- Self-pay 31%
Source: Private Healthcare Information Network (PHIN), 2026[3]
Show the data
| Item | Value |
|---|---|
| Insured | 69% |
| Self-pay | 31% |
Screening differs from diagnostic testing in one important way: the person has no symptoms. That changes the balance of benefit and harm. A false positive in a healthy person can lead to anxiety, further tests and sometimes procedures they never needed. A false negative can give false reassurance. A clinic that sells screening takes on responsibility for that balance.
Use the national benchmark
The UK National Screening Committee advises ministers and the NHS in the four UK countries on all aspects of screening[1]. It looks at whether a test is accurate, whether early detection improves outcomes, and whether the benefits outweigh the harms across a population. Where it has decided not to recommend population screening for a condition, a private clinic offering that screen to healthy people should be able to explain why its offer is different, for example because it is targeted at people with a family history.
Know what the NHS already offers. The NHS Health Check is offered every five years to people aged 40 to 74 who do not already have conditions such as heart disease, diabetes or high blood pressure, and covers blood pressure, cholesterol, BMI and a 10-year cardiovascular risk score[4]. Patients who are eligible should be told, so they do not pay for something they could get free.
Four questions before you offer a screen
| Question | Good answer | Warning sign |
|---|---|---|
| Is there a clear target condition? | The test looks for a defined condition with known treatment | A broad scan looking for 'anything' |
| Is the test accurate in this group? | Known sensitivity and specificity for people like your patients | Accuracy only known in people with symptoms |
| Does early detection help? | Treatment is more effective when found early | No change to what would be done anyway |
| Can you manage the results? | A pathway exists for positives and incidental findings | Abnormal results are simply sent to the GP |
If you cannot give a good answer to all four for a given test, redesign the package or present it as a test for people with a specific reason, rather than general screening.
Consent that covers the consequences
Consent for screening is not just agreement to have a sample taken or a scan done. It must cover what the result might lead to. A patient should understand before the test that a result may be uncertain, that further tests may be needed, and who will pay for them.
- What the test looks for and what it cannot rule out.
- How often the test gives a false alarm in people like them, in plain words.
- What happens after an abnormal result, including possible further tests and their cost.
- What happens to incidental findings, the things you were not looking for.
- Whether results will be shared with their NHS GP, and what you will do if they say no.
Script for the consent conversation: 'Before we go ahead, I want to explain what this test can and can't tell you. Most people get a normal result. A small number get a result that needs another test to be sure, and most of those turn out to be fine. If that happens, we'll arrange the next step with you. Are you happy with that?'
Who owns the follow-up
The provider that performs a screen owns the result. Sending an abnormal finding to the patient's GP with a note saying 'please action' moves work into a stretched NHS system without the patient's agreement and without clinical context. Before launch, decide what your clinic will do for each likely result.
Map the likely findings
For each test, list the common abnormal results and the likely incidental findings.
Decide your response
For each, decide whether you will repeat, investigate, refer privately or refer to the NHS via the GP.
Set timescales
Agree how quickly each type of result is reviewed and communicated.
Write the GP letter template
If you write to the GP, include the result, your interpretation, what you have told the patient and what you are asking for.
Audit
Review a sample of abnormal results every quarter to check they were handled to plan.
Incidental findings are the hidden cost
Broad screens, especially imaging, often find things nobody was looking for: a small cyst, a borderline blood value, a shadow that is probably nothing. Each one needs a decision, a conversation and sometimes another test. Budget clinician time for them, decide in advance which findings you will act on and which you will simply report, and tell patients this before the screen.
- Write a short list of common incidental findings for each test and the agreed response.
- Decide who pays for further tests that follow an incidental finding, and say so in your terms.
- Keep a log of incidental findings and what happened, so the clinical lead can review it.
When a patient wants everything checked
Some patients arrive anxious and ask for every test available. More tests are not always kinder. Spend the first part of the appointment on the reason for their worry: a family history, a symptom they have not mentioned, a recent bereavement. A targeted test with a clear plan is usually more reassuring than a long list of numbers.
Script: 'I understand you want to be sure nothing is missed. Running lots of tests at once can actually create more uncertainty, because some results come back slightly outside the range for no real reason. Let's look at what's worrying you most and choose the tests that will answer that properly.'
Regulation and claims
In England, diagnostic and screening procedures are a regulated activity[5], so a clinic offering screening must be registered for it. Marketing must be accurate. Avoid words such as 'complete', 'full body' or 'peace of mind guaranteed', which suggest a certainty no screen can give. Describe what each package measures and who it is for.
Health data collected during screening is special category data under UK GDPR[6]. Questionnaires, images and results should live in the clinical record, with retention periods set and any third-party labs or imaging partners under written contracts.
Designing an ethical package
Example: a fictional clinic in Manchester replaced its 'executive full body check' with three packages built around reasons: a cardiovascular risk review for people with a family history, a menopause-focused assessment, and a sports pre-participation check. Each package lists the tests, explains who it suits, and includes a clinician conversation and one follow-up. Enquiries went down slightly, but complaints and requests for refunds after abnormal results fell sharply because patients knew what to expect.
- Start from the patient's reason, not from the list of tests a lab can run.
- Include clinician time to explain results, and say so.
- State what is not included, such as further imaging after an abnormal result.
- Tell eligible patients about the NHS Health Check and national screening programmes.
Review the package list every year
Screening evidence changes. National recommendations are updated, new tests appear and old ones are shown to be less useful than thought. Put a yearly review in the diary, led by the clinical lead, that looks at each package against the four questions above, the latest national advice and your own audit data. Retire packages that no longer pass, even if they sell well, and record the reason.
- Check each test against current national screening advice.
- Review your own figures on abnormal results, further tests and confirmed findings.
- Read every complaint linked to screening from the past year.
- Update patient information and consent forms to match any changes.
Measuring whether the service is doing good
Track more than sales. Useful measures include the share of screens with an abnormal result, the share of those that led to further tests, the share of further tests that confirmed a problem, the time from result to conversation, and complaints. If most abnormal results turn out to be nothing, the package is causing more worry than it prevents and needs redesign.
Frequently asked questions
Is private health screening worth it?
It depends on the test and the person. Screening is most useful when it targets a defined condition, the test is accurate in that group and early detection improves outcomes. The UK National Screening Committee's advice is a useful benchmark[1].
Who follows up an abnormal private screening result?
The provider that performed the screen should own the follow-up, including incidental findings, and agree any onward referral with the patient.
Can patients get a free health check on the NHS?
People aged 40 to 74 without certain existing conditions are invited for an NHS Health Check every five years[4].
Does a screening clinic need CQC registration?
In England, diagnostic and screening procedures are a regulated activity, so the provider must be registered for it[5].
References
GOV.UK (UK National Screening Committee) (2026). UK National Screening Committee (opens in a new tab) ↑
Independent Healthcare Providers Network (IHPN) (2026). Support for using private healthcare now found across the political spectrum, new report shows (opens in a new tab) ↑
Private Healthcare Information Network (PHIN) (2026). Private healthcare market update: September 2026 United Kingdom (opens in a new tab) ↑
NHS (nhs.uk) (2026). NHS Health Check (opens in a new tab) ↑
legislation.gov.uk (The National Archives) (2014). The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Schedule 1: regulated activities (opens in a new tab) ↑
legislation.gov.uk (The National Archives) (2026). UK GDPR Article 9: Processing of special categories of personal data (opens in a new tab) ↑